Transcend Capital Advisors, LLC Amicus Therapeutics, Inc. Transaction History

Transcend Capital Advisors, LLC

$1.44 Billion
Q3 2024

A detailed history of Transcend Capital Advisors, LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Transcend Capital Advisors, LLC holds 326,854 shares of FOLD stock, worth $2.95 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

326,854

Previous 330,327 1.05%

Holding current value

$2.95 Million

Previous $3.28 Million 6.53%

% of portfolio

0.24%

Previous 0.24%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$9.55 - $12.09 $33,167 - $41,988	-3,473 Reduced 1.05%	326,854 $3.49 Million
Q2 2024 Jul 02, 2024	BUY	$9.04 - $11.75 $180,845 - $235,058	20,005 Added 6.45%	330,327 $3.28 Million
Q1 2024 May 03, 2024	BUY	$11.43 - $14.24 $3,931 - $4,898	344 Added 0.11%	310,322 $3.66 Million
Q4 2023 Feb 05, 2024	BUY	$9.97 - $14.52 $234,035 - $340,842	23,474 Added 8.19%	309,978 $4.4 Million
Q3 2023 Oct 31, 2023	BUY	$11.78 - $13.86 $4,229 - $4,975	359 Added 0.13%	286,504 $3.48 Million
Q2 2023 Jul 13, 2023	BUY	$10.72 - $13.3 $747,033 - $926,823	69,686 Added 32.19%	286,145 $3.59 Million
Q1 2023 Apr 12, 2023	BUY	$10.91 - $13.54 $8,433 - $10,466	773 Added 0.36%	216,459 $2.4 Million
Q4 2022 Jan 20, 2023	BUY	$9.89 - $12.7 $6,102 - $7,835	617 Added 0.29%	215,686 $0
Q3 2022 Oct 17, 2022	BUY	$9.82 - $12.75 $185,332 - $240,630	18,873 Added 9.62%	215,069 $2.25 Million
Q2 2022 Jul 12, 2022	BUY	$6.23 - $11.12 $330,034 - $589,082	52,975 Added 36.99%	196,196 $2.11 Million
Q1 2022 Apr 20, 2022	BUY	$7.89 - $12.48 $9,128 - $14,439	1,157 Added 0.81%	143,221 $1.36 Million
Q4 2021 Jan 20, 2022	SELL	$9.82 - $12.44 $7,856 - $9,952	-800 Reduced 0.56%	142,064 $1.64 Million
Q3 2021 Nov 04, 2021	BUY	$8.74 - $11.84 $15,732 - $21,312	1,800 Added 1.28%	142,864 $1.48 Million
Q2 2021 Aug 13, 2021	SELL	$8.71 - $10.72 $34,840 - $42,880	-4,000 Reduced 2.76%	141,064 $1.36 Million
Q1 2021 May 12, 2021	BUY	$9.2 - $23.86 $323,922 - $840,086	35,209 Added 32.05%	145,064 $1.43 Million
Q4 2020 Feb 12, 2021	BUY	$13.47 - $24.89 $1.48 Million - $2.73 Million	109,855 New	109,855 $2.54 Million

Others Institutions Holding FOLD

# of Institutions

311

Shares Held

314M

Call Options Held

516K

Put Options Held

833K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.53B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Transcend Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Transcend Capital Advisors, LLC with notifications on news.

Account

Transcend Capital Advisors, LLC Amicus Therapeutics, Inc. Transaction History